Clinical Trials Directory

Trials / Completed

CompletedNCT05734859

Drinking Effect of Electrolyzed Alkaline Reduced Water on Functional Constipation

A Pilot Study of Drinking Electrolyzed Hydrogen-rich Alkaline Reduced Water Generated by Alkaline Ionizer (BTM-1200) on the Chronic Functional Constipation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Wonju Severance Christian Hospital · Academic / Other
Sex
All
Age
19 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to investigate drinking effect of electrolyzed hydrogen-rich alkaline reduced water (EHARW) in chronic constipation patients. The main question is that drinking EHARW will improve the symptoms of chronic constipation for 4 weeks. Participants will drink EHARW (20 mL/kg of body weight/day) generated from the experimental device for 4 weeks.

Detailed description

Patients diagnosed with constipation will be recruited and screened according to the inclusion and exclusion criteria after sign in the informed consent form. The selected patients will be enrolled. The experimental device (BTM-1200, Bion-Tech, Gyeonggi-do, Korea) will be installed at each patient's house. The researcher will instruct patients drinking method. The patients will drink a total of 20 mL/kg of body weight/day of EHARW (pH 9.5) in 3-different times, and drink directly from the device on an empty stomach for 4 weeks. The clinical trial is conducted in a single group without a control group, and the efficacy is evaluated by comparing the symptoms of constipation pre- and post-intervention. The primary outcome is the proportion of responders based on frequency of complete complete spontaneous bowel movement (CSBM).

Conditions

Interventions

TypeNameDescription
DEVICEElectrolyzed Alkaline IonizerPatients will drink EHARW calculated by 20 mL/kg body weight/day which can be divided into several times a day for drinking. The patient is recommended to drink water in an empty stomach and to drink water generated from the device as soon as possible.

Timeline

Start date
2022-11-30
Primary completion
2023-01-13
Completion
2023-01-13
First posted
2023-02-21
Last updated
2023-04-03

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05734859. Inclusion in this directory is not an endorsement.